ERK-associated changes in E2F4 phosphorylation, localization and transcriptional activity during mitogenic stimulation in human intestinal epithelial crypt cells
Open Access
- 6 August 2013
- journal article
- Published by Springer Nature in BMC Cell Biology
- Vol. 14 (1) , 33
Abstract
Background: The transcription factor E2F4 controls proliferation of normal and cancerous intestinal epithelial cells. E2F4 localization in normal human intestinal epithelial cells (HIEC) is cell cycle-dependent, being cytoplasmic in quiescent differentiated cells but nuclear in proliferative cells. However, the intracellular signaling mechanisms regulating such E2F4 localization remain unknown. Results: Treatment of quiescent HIEC with serum induced ERK1/2 activation, E2F4 phosphorylation, E2F4 nuclear translocation and G1/S phase transition while inhibition of MEK/ERK signaling by U0126 prevented these events. Stimulation of HIEC with epidermal growth factor (EGF) also led to the activation of ERK1/2 but, in contrast to serum or lysophosphatidic acid (LPA), EGF failed to induce E2F4 phosphorylation, E2F4 nuclear translocation and G1/S phase transition. Furthermore, Akt and GSK3β phosphorylation levels were markedly enhanced in serum- or LPA-stimulated HIEC but not by EGF. Importantly, E2F4 phosphorylation, E2F4 nuclear translocation and G1/S phase transition were all observed in response to EGF when GSK3 activity was concomitantly inhibited by SB216763. Finally, E2F4 was found to be overexpressed, phosphorylated and nuclear localized in epithelial cells from human colorectal adenomas exhibiting mutations in APC and KRAS or BRAF genes, known to deregulate GSK3/β-catenin and MEK/ERK signaling, respectively. Conclusions: The present results indicate that MEK/ERK activation and GSK3 inhibition are both required for E2F4 phosphorylation as well as its nuclear translocation and S phase entry in HIEC. This finding suggests that dysregulated E2F4 nuclear localization may be an instigating event leading to hyperproliferation and hence, of tumor initiation and promotion in the colon and rectum.Keywords
This publication has 52 references indexed in Scilit:
- E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cellsJournal of Cellular Physiology, 2009
- Nuclear cyclin D1: An oncogenic driver in human cancerJournal of Cellular Physiology, 2009
- E2F – at the crossroads of life and deathTrends in Cell Biology, 2008
- From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb‐E2F pathwayJournal of Cellular Biochemistry, 2007
- Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA‐binding capacityJournal of Cellular Physiology, 2007
- Mitogenic signaling pathways induced by G protein‐coupled receptorsJournal of Cellular Physiology, 2007
- Colorectal cancer: genetics of development and metastasisJournal of Gastroenterology, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiationJournal of Cellular Physiology, 2003
- Developmental expression of two antigens associated with mouse intestinal cryptsDevelopmental Dynamics, 1992